# Priya Sandoval, Former Head of Sales Ops (Health IT, now independent) — read of Healthcare Practice Expansion Lead Feed, June 20 2026

> 11 years in B2B sales ops, last 4 at a health IT company selling EHR integrations to mid-size clinics. Left in February. 6 months of runway, a 7-year-old in second grade, and a habit of doing trail runs at 5:30 AM because it's the only hour nobody needs anything from me.

## How I got here

Someone in a Slack community I'm in for indie operators posted a link with the comment "has anyone tried Wishdeal." I did not recognize the name. I Googled it first before clicking, found nothing alarming, then came back and opened the page. I was specifically thinking about a data product in the healthcare space because I spent 4 years watching our AEs scramble to find new clinic openings before our competitor did. This felt adjacent to a real problem I know.

## What I clicked first

The hero line "Catch Healthcare Practice Expansion Before Your Competition" is genuinely the right frame. It's the actual pain. I've said that sentence in internal Slack channels verbatim. That pulled me in. Then I noticed "Real-time monitoring of healthcare practice openings, relocations, and expansion announcements across the US" and "NPI registry changes" as a named source. NPI is a real thing. Someone here has thought about this more than 20 minutes.

## Where I paused

The scoring block. Specifically: "-$17,900 Year-1 take-home (Fermi)" and "1 in 8 Meaningful-success odds." I have never seen a product page voluntarily tell me the odds are probably bad. I sat with that for a while. It's either the most disarming thing I've read on a product page in years or it's a low-stakes disclaimer designed to build false trust before I hand over $99. I genuinely do not know which one yet.

## What I distrusted

"See which practices your competitors are targeting and track market expansion trends." This is a feature claim on a product that, by the page's own admission, has zero live customers. How exactly does competitive intelligence work when nobody is using the product? What competitors? Whose targeting data? This reads like a feature brainstorm that made it into the copy without anyone asking "wait, how does this actually work right now?"

Also: "We shipped the strategy package; you ship the customer conversations." I understand what they're saying but this is doing a lot of work. The whole pitch is that NPI registry changes are a real signal and enriched decision-maker data is genuinely useful. But enrichment quality is everything in this space. Apollo is riddled with stale contacts. ZoomInfo is expensive and still wrong sometimes. The page does not say anything about where the enrichment comes from or how fresh it is.

And "Compliance-Ready Outreach" is a phrase that sounds like a lawyer approved it but doesn't actually tell me anything specific. HIPAA? CAN-SPAM? TCPA? Which compliance, for what kind of outreach?

## What would convince me

One real NPI event parsed into an actual lead record, shown on the page. Not a mockup. An actual expansion event from three weeks ago, the practice name, the NPI change date, the enriched contact (name and title, email redacted), and what action they took. One concrete example beats every bullet point on this page.

Also: tell me the enrichment source. If it's Apollo or Clearbit underneath, I can evaluate that. If it's something proprietary, explain what "verified" means. The word "verified" appears once and does no work.

## What I'd ask in an email reply

1. The NPI registry is public but parsing it into actionable expansion signals is the hard part. What specifically triggers a "new location signal" -- is it a new NPI filing, a new group practice enrollment, a change in practice address? How do you filter noise from routine address corrections?

2. The $5 dossier unlocks the ICP and build plan, and the $99 includes "working code starter." What does working code mean here -- a scraper scaffold, a cron job hitting an API, something else? I want to know the actual starting point so I can evaluate whether $99 is reasonable or a way to get me to pay twice before I realize I need $500 in API credits to run it.

3. You scored buyer clarity 10/10, which I agree with -- health IT vendors, staffing agencies, device reps all want this. But you scored financial upside 2/10. Is the upside problem the market size, the pricing ceiling, or the cost of data acquisition? Because those are three very different problems.

## Verdict: curious-enough-to-reply

The self-disclosed negative year-1 projection and the "1 in 8 odds" either mean these people are unusually honest or unusually clever, and I want to know which. The underlying data source (NPI registry) is real and the pain is real. The feature claims outpace what's actually been built, but at $5 to find out more, the bar to click is low enough that I'd rather read the dossier than speculate.

---
*Memo by skeptic persona, generated 2026-06-20. Studio breaks own self-grading loop.*